Allergan announced the CoolSculpting Elite device, a new iteration of its cryolipolysis platform. The Elite designation typically signals hardware or software improvements—faster treatment cycles, enhanced ergonomics, or refined applicator geometry—though the specific clinical or operational advantages require deeper review of the actual specifications.
Devices & Tech
Allergan Launches CoolSculpting Elite Device
Allergan has announced the CoolSculpting Elite, an updated cryolipolysis platform.
1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
CoolSculpting Elite is an incremental refresh in a crowded cryolipolysis market.
Cryolipolysis remains a workhorse in body contouring, especially as GLP-1 weight-loss drug adoption drives demand for residual fat reduction and skin tightening. CoolSculpting's installed base and brand recognition give Allergan a structural advantage, but the device market is competitive: Zeltiq (now part of Allergan), Cooltech, and others compete on treatment time, downtime, and cost per treatment. The Elite launch is an incremental refresh, not a category disruption. Practices should evaluate whether the upgrade justifies equipment replacement or whether existing CoolSculpting systems remain sufficient for current patient volume.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.